The role of Atogepant in migraine prevention: a systematic review and meta-analysis

Abstract Background Atogepant is a CGRP receptor antagonist used in prevention of migraine. This study assesses the safety and efficacy of this drug in management of migraine headaches. Methods PubMed, Scopus, Web of Science, and Cochrane CENTRAL were searched until March 24, 2025. Outcomes assessed...

Full description

Bibliographic Details
Published in:BMC Neurology
Main Authors: Naresh Kumar Ladhwani, Priya Bai, Rohan Lal, Aresha Masood Shah, Sheela Bai, Ghazi Uddin Ahmed, Rimsha Zameer, Varisha Fatima Shaikh, Arsalan Hyder, Sikander Ali, Muhammad Hamza Beg, Maheen Adeeb, Mahir Tesfaye
Format: Article
Language:English
Published: BMC 2025-09-01
Subjects:
Atogepant
CGRP antagonist
Chronic migraine
Episodic migraine
Meta-analysis
Online Access:https://doi.org/10.1186/s12883-025-04394-z

Internet

https://doi.org/10.1186/s12883-025-04394-z

Similar Items